Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse-Remitting Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02988401
What this trial is testing

Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Primary Progressive
Johns Hopkins University 105
Testing effectiveness (Phase 2)Looking for participantsNCT05359653
What this trial is testing

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Who this might be right for
Multiple Sclerosis (MS)Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary Progressive+4 more
University of California, San Francisco 74
Not applicableStudy completedNCT01945359
What this trial is testing

Pilot Study to Assess Disease Stability in a Natalizumab to Dimethyl Fumarate Crossover Design

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Rocky Mountain MS Research Group, LLC 30
Not applicableLooking for participantsNCT05204459
What this trial is testing

MS-ResearchBiomarkerS

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary Progressive+8 more
Cedars-Sinai Medical Center 1,000
Not applicableLooking for participantsNCT07426991
What this trial is testing

Cognitive Performance, Sleep Disturbances and Fatigue in Multiple Sclerosis

Who this might be right for
Multiple SclerosisRemitting-Relapsing Multiple SclerosisPrimary Progressive Multiple Sclerosis+3 more
Heinrich-Heine University, Duesseldorf 837
Testing effectiveness (Phase 2)Study completedNCT01081782
What this trial is testing

The Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Ono Pharma USA Inc 407
Testing effectiveness (Phase 2)Ended earlyNCT00239655
What this trial is testing

Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI)(0812-003)(COMPLETED)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Merck Sharp & Dohme LLC 120
Testing effectiveness (Phase 2)Study completedNCT00390221
What this trial is testing

Safety and Efficacy Study of Daclizumab High Yield Process (DAC HYP) to Treat Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 621
Not applicableStudy completedNCT01805336
What this trial is testing

Assessment of Attentional and Executive Disorders in Multiple Sclerosis Using Techniques of Virtual Reality

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
University Hospital, Caen 60
Not applicableStudy completedNCT03408093
What this trial is testing

Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b

Who this might be right for
Multiple Sclerosis
Bayer 120
Post-approval studies (Phase 4)Study completedNCT02064816
What this trial is testing

Rebif® in Subjects With Relapsing Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Merck KGaA, Darmstadt, Germany 200
Testing effectiveness (Phase 2)Study completedNCT00349193
What this trial is testing

Evaluate the Effectiveness, Tolerability and Safety of Laquinimod

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 306
Large-scale testing (Phase 3)Study completedNCT00420212
What this trial is testing

Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 1,234
Testing effectiveness (Phase 2)Study completedNCT02493049
What this trial is testing

Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
University of Calgary 17
Post-approval studies (Phase 4)Study completedNCT02019550
What this trial is testing

Rebif® Rebidose® Versus Rebiject II® Ease-of-Use

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
EMD Serono 97
Not applicableUnknownNCT04380220
What this trial is testing

Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis

Who this might be right for
Multiple SclerosisRelapse
Regina Elena Cancer Institute 80
Testing effectiveness (Phase 2)Ended earlyNCT01874340
What this trial is testing

Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 28
Not applicableUnknownNCT04993274
What this trial is testing

Sensitivity of Motor Assessment in MS - a Prospective Cohort Study

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Chronic Progressive
Friedemann Paul 100
Not applicableActive Not RecruitingNCT06884579
What this trial is testing

Educational Programs Based on Healthy Habits to Improve Quality of Life and Psychosocial Profile in Women With Neurodegenerative Diseases: the ADVICE Protocol Study (Phase 2)

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remitting
Universidad de Almeria 60
Not applicableStudy completedNCT01848327
What this trial is testing

Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis

Who this might be right for
Relapsing Remitting MSSecondary Progressive MSPrimary Progressive MS
University of Miami 124
Next Page